PUBLICATIONS · 7683043
Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1993 Apr
- First author
- Kelly WK
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 1993 Apr;11(4):596-7. doi: 10.1200/JCO.1993.11.4.596.
- note
- Source null
- related pmid
- 7683042
- relationship
- Comment in
Authors and identifiers
- name
- Kelly WK
- type
- Author
- name
- Scher HI
- type
- Author
- name
- Mazumdar M
- type
- Author
- name
- Vlamis V
- type
- Author
- name
- Schwartz M
- type
- Author
- name
- Fossa SD
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kelly WK
- type
- Author
- name
- Scher HI
- type
- Author
- name
- Mazumdar M
- type
- Author
- name
- Vlamis V
- type
- Author
- name
- Schwartz M
- type
- Author
- name
- Fossa SD
- type
- Author
- bibliography ids
- nci-bib-66836ac1c3189ec20b641333
- book metadata
- content sha256
- f208ae680623c4e2ca807c7e9f4950cdf3c662b66237eff6d6b44677913f160e
- document type
- citation
- dois
- 10.1200/JCO.1993.11.4.607
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:7683043
- immutable id
- pubmed:7683043@f208ae680623c4e2ca807c7e9f4950cdf3c662b66237eff6d6b44677913f160e
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 4
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 607-15
- volume
- 11
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 1993 Apr;11(4):596-7. doi: 10.1200/JCO.1993.11.4.596.
- note
- Source null
- related pmid
- 7683042
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 7683043
- provenance
- batch id
- 0195e80d659ca3142556
- provider
- NCBI PubMed ESummary
- record sha256
- c531eadb21300e5798f02fdf4b37740f7576da9abb50af66b75e65e26acea16a
- response sha256
- 021698996c455bb1930ebf197fc7e88fce61693e192449206cc5457c0644e062
- retrieved at
- 2026-09-09T23:45:16.849437+00:00
- publication date
- display
- 1993 Apr
- precision
- month
- year
- 1993
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/7683043/
- title
- Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer.
Preserved source evidence · Not medical advice
Triangle